C5a peptidase alters clearance and trafficking of group A streptococci by infected mice (original) (raw)

Abstract

Group A streptococcal C5a peptidase (SCPA) specifically cleaves the human serum chemotaxin C5a at the polymorphonuclear leukocyte (PMNL) binding site. This study tested the proposal that SCPA contributes to virulence by retarding the influx of inflammatory cells and clearance of streptococci during the first few hours after infection. To investigate the specific contribution of SCPA to the virulence of group A streptococci, scpA insertion and deletion mutants were created by directed plasmid insertion into scpA and gene replacement. The precise locations of insertion and deletion mutations were confirmed by PCR and DNA sequence analysis. The impact of mutation on virulence was investigated with a mouse air sac model of inflammation. Experiments evaluated clearance of streptococci from the air sac within 4 h after infection. SCPA- streptococci were cleared more efficiently than wild-type bacteria. Localization of streptococci in lymph nodes and spleens of infected mice revealed a significant difference between mutant and wild-type streptococci. PMNLs and other granulocytes that infiltrated the air sac were quantitated by single-color flow cytometry. The total cellular infiltrate was greater and PMNLs dominated the granulocytic infiltrates of air sacs inoculated with SCPA- mutant bacteria. The data obtained are consistent with the possibility that SCPA- streptococci are initially cleared from the site of infection primarily by PMNLs. Moreover, mutant and wild-type streptococci followed different paths of dissemination. SCPA- bacteria were transported to lymph nodes, whereas wild-type streptococci avoided transport to the lymph nodes and rapidly spread to the spleen.

Full Text

The Full Text of this article is available as a PDF (323.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biswas I., Gruss A., Ehrlich S. D., Maguin E. High-efficiency gene inactivation and replacement system for gram-positive bacteria. J Bacteriol. 1993 Jun;175(11):3628–3635. doi: 10.1128/jb.175.11.3628-3635.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bohnsack J. F., Chang J. K., Hill H. R. Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species. Infect Immun. 1993 Apr;61(4):1421–1426. doi: 10.1128/iai.61.4.1421-1426.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Booth S. A., Moody C. E., Dahl M. V., Herron M. J., Nelson R. D. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992 Feb;98(2):135–140. doi: 10.1111/1523-1747.ep12555654. [DOI] [PubMed] [Google Scholar]
  4. Boyle M. D., Lawman M. J., Gee A. P., Young M. Measurement of leukocyte chemotaxis in vivo. Methods Enzymol. 1988;162:101–114. doi: 10.1016/0076-6879(88)62068-4. [DOI] [PubMed] [Google Scholar]
  5. Brummer E., Sugar A. M., Stevens D. A. Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol. 1984 Oct;36(4):505–520. doi: 10.1002/jlb.36.4.505. [DOI] [PubMed] [Google Scholar]
  6. Chen C. C., Cleary P. P. Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene. Infect Immun. 1989 Jun;57(6):1740–1745. doi: 10.1128/iai.57.6.1740-1745.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen C. C., Cleary P. P. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem. 1990 Feb 25;265(6):3161–3167. [PubMed] [Google Scholar]
  8. Clark J. M., Menduke H., Wheelock E. F. A new method for quantitation of cell-mediated immunity in the mouse. J Reticuloendothel Soc. 1979 Mar;25(3):255–267. [PubMed] [Google Scholar]
  9. Cleary P. P., Handley J., Suvorov A. N., Podbielski A., Ferrieri P. Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun. 1992 Oct;60(10):4239–4244. doi: 10.1128/iai.60.10.4239-4244.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cleary P. P., Peterson J., Chen C., Nelson C. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun. 1991 Jul;59(7):2305–2310. doi: 10.1128/iai.59.7.2305-2310.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cleary P. P., Prahbu U., Dale J. B., Wexler D. E., Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun. 1992 Dec;60(12):5219–5223. doi: 10.1128/iai.60.12.5219-5223.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Courtney H. S., Bronze M. S., Dale J. B., Hasty D. L. Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect Immun. 1994 Nov;62(11):4868–4873. doi: 10.1128/iai.62.11.4868-4873.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fischetti V. A. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989 Jul;2(3):285–314. doi: 10.1128/cmr.2.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gomi H., Hozumi T., Hattori S., Tagawa C., Kishimoto F., Björck L. The gene sequence and some properties of protein H. A novel IgG-binding protein. J Immunol. 1990 May 15;144(10):4046–4052. [PubMed] [Google Scholar]
  15. Heath D. G., Cleary P. P. Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus. Infect Immun. 1987 May;55(5):1233–1238. doi: 10.1128/iai.55.5.1233-1238.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hill H. R., Bohnsack J. F., Morris E. Z., Augustine N. H., Parker C. J., Cleary P. P., Wu J. T. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol. 1988 Nov 15;141(10):3551–3556. [PubMed] [Google Scholar]
  17. Hollingshead S. K., Simecka J. W., Michalek S. M. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect Immun. 1993 Jun;61(6):2277–2283. doi: 10.1128/iai.61.6.2277-2283.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ivey C. L., Williams F. M., Collins P. D., Jose P. J., Williams T. J. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest. 1995 Jun;95(6):2720–2728. doi: 10.1172/JCI117974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Larsen G. L., Mitchell B. C., Harper T. B., Henson P. M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis. 1982 Aug;126(2):306–311. doi: 10.1164/arrd.1982.126.2.306. [DOI] [PubMed] [Google Scholar]
  21. McLandsborough L. A., Cleary P. P. Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein. FEMS Microbiol Lett. 1995 Apr 15;128(1):45–51. doi: 10.1111/j.1574-6968.1995.tb07498.x. [DOI] [PubMed] [Google Scholar]
  22. O'Connor S. P., Cleary P. P. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis. 1987 Sep;156(3):495–504. doi: 10.1093/infdis/156.3.495. [DOI] [PubMed] [Google Scholar]
  23. O'Connor S. P., Cleary P. P. Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun. 1986 Aug;53(2):432–434. doi: 10.1128/iai.53.2.432-434.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Raeder R., Boyle M. D. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun. 1993 Apr;61(4):1378–1384. doi: 10.1128/iai.61.4.1378-1384.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reis K. J., Yarnall M., Ayoub E. M., Boyle M. D. Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol. 1984 Nov;20(5):433–439. doi: 10.1111/j.1365-3083.1984.tb01022.x. [DOI] [PubMed] [Google Scholar]
  26. Repo H. Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. I. Effects of environmental factors on neutrophil migration under agarose. Scand J Immunol. 1977;6(3):203–209. doi: 10.1111/j.1365-3083.1977.tb00385.x. [DOI] [PubMed] [Google Scholar]
  27. Simpson W. J., Cleary P. P. Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun. 1987 Oct;55(10):2448–2455. doi: 10.1128/iai.55.10.2448-2455.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Simpson W. J., LaPenta D., Chen C., Cleary P. P. Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol. 1990 Feb;172(2):696–700. doi: 10.1128/jb.172.2.696-700.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Snyderman R., Phillips J. K., Mergenhagen S. E. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med. 1971 Nov 1;134(5):1131–1143. doi: 10.1084/jem.134.5.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Springer T., Galfré G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979 Apr;9(4):301–306. doi: 10.1002/eji.1830090410. [DOI] [PubMed] [Google Scholar]
  31. Stevens D. L. Invasive group A streptococcus infections. Clin Infect Dis. 1992 Jan;14(1):2–11. doi: 10.1093/clinids/14.1.2. [DOI] [PubMed] [Google Scholar]
  32. Wessels M. R., Bronze M. S. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12238–12242. doi: 10.1073/pnas.91.25.12238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wexler D. E., Chenoweth D. E., Cleary P. P. Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8144–8148. doi: 10.1073/pnas.82.23.8144. [DOI] [PMC free article] [PubMed] [Google Scholar]